美国 · SEC FORM 4
LivaNova PLC
LIVN · Nasdaq · CIK 0001639691 · Healthcare · Medical Devices
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
29 同一窗口内观察到的 Form 4 交易行
6 sales · 23 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 4 additional owner(s) remain in Form 4 申报证据.
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2021-11-10 · KOZY WILLIAM A.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 6,003,050
- 上期报告
- 5,375,448
- 日均成交量
- 747,064
- 回补天数
- 8.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
Form 4 申报证据
39 transaction lines in the latest 365-day window; 448 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-10 | Bianchi Francesco | 卖出 (S) | Ordinary Shares | 3,500 | USD 78.01 | USD 273,035 | SEC 申报 ↗ |
| 2026-09-04 | Story Brooke | 卖出 (S) | Ordinary Shares | 2,300 | USD 81.42 | USD 187,266 | SEC 申报 ↗ |
| 2026-08-31 | Bianchi Francesco | 卖出 (S) | Ordinary Shares | 1,650 | USD 79.72 | USD 131,538 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-10 | Bianchi Francesco | 卖出 (S) | Ordinary Shares | 3,500 | USD 78.01 | USD 273,035 | SEC 申报 ↗ |
| 2026-09-04 | Story Brooke | 卖出 (S) | Ordinary Shares | 2,300 | USD 81.42 | USD 187,266 | SEC 申报 ↗ |
| 2026-08-31 | Bianchi Francesco | 卖出 (S) | Ordinary Shares | 1,650 | USD 79.72 | USD 131,538 | SEC 申报 ↗ |
| 2026-08-11 | Tezel Ahmet | 卖出 (S) | Ordinary Shares | 2,675 | USD 77.74 | USD 207,954 | SEC 申报 ↗ |
| 2026-08-11 | Tezel Ahmet | 期权行权／转换 (M) | Ordinary Shares | 12,692 | USD 52.68 | USD 668,615 | SEC 申报 ↗ |
| 2026-08-11 | Tezel Ahmet | 代扣税 (F) | Ordinary Shares | 1,428 | USD 77.86 | USD 111,184 | SEC 申报 ↗ |
| 2026-08-11 | Tezel Ahmet | D (D) | Ordinary Shares | 8,589 | USD 77.86 | USD 668,740 | SEC 申报 ↗ |
| 2026-06-15 | Zurbay Donald | 期权行权／转换 (M) | Ordinary Shares | 2,560 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-15 | Zurbay Donald | 代扣税 (F) | Ordinary Shares | 308 | USD 79.70 | USD 24,548 | SEC 申报 ↗ |
| 2026-06-15 | WILVER PETER M | 期权行权／转换 (M) | Ordinary Shares | 4,042 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-15 | WILVER PETER M | 代扣税 (F) | Ordinary Shares | 486 | USD 79.70 | USD 38,734 | SEC 申报 ↗ |
| 2026-06-15 | Tezel Ahmet | 期权行权／转换 (M) | Ordinary Shares | 2,965 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-15 | Tezel Ahmet | 代扣税 (F) | Ordinary Shares | 1,032 | USD 79.70 | USD 82,250 | SEC 申报 ↗ |
| 2026-06-15 | Story Brooke | 期权行权／转换 (M) | Ordinary Shares | 4,042 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-15 | Story Brooke | 代扣税 (F) | Ordinary Shares | 486 | USD 79.70 | USD 38,734 | SEC 申报 ↗ |
| 2026-06-15 | SCHERMERHORN TODD C | 期权行权／转换 (M) | Ordinary Shares | 4,042 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-15 | SCHERMERHORN TODD C | 代扣税 (F) | Ordinary Shares | 486 | USD 79.70 | USD 38,734 | SEC 申报 ↗ |
| 2026-06-15 | PODLOGAR SUSAN M | 期权行权／转换 (M) | Ordinary Shares | 4,042 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-15 | PODLOGAR SUSAN M | 代扣税 (F) | Ordinary Shares | 486 | USD 79.70 | USD 38,734 | SEC 申报 ↗ |
| 2026-06-15 | KOZY WILLIAM A | 期权行权／转换 (M) | Ordinary Shares | 5,681 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-15 | KOZY WILLIAM A | 代扣税 (F) | Ordinary Shares | 682 | USD 79.70 | USD 54,355 | SEC 申报 ↗ |
| 2026-06-15 | Enxing Seng Stacy | 期权行权／转换 (M) | Ordinary Shares | 4,042 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-15 | Enxing Seng Stacy | 代扣税 (F) | Ordinary Shares | 486 | USD 79.70 | USD 38,734 | SEC 申报 ↗ |
| 2026-06-15 | Bianchi Francesco | 卖出 (S) | Ordinary Shares | 1,200 | USD 80.19 | USD 96,228 | SEC 申报 ↗ |
| 2026-06-15 | Bianchi Francesco | 期权行权／转换 (M) | Ordinary Shares | 4,042 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-15 | Bianchi Francesco | 代扣税 (F) | Ordinary Shares | 486 | USD 79.70 | USD 38,734 | SEC 申报 ↗ |
| 2026-06-15 | Barry James Christopher | 期权行权／转换 (M) | Ordinary Shares | 4,042 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-15 | Barry James Christopher | 代扣税 (F) | Ordinary Shares | 486 | USD 79.70 | USD 38,734 | SEC 申报 ↗ |
| 2026-05-26 | Bianchi Francesco | 卖出 (S) | Ordinary Shares | 1,800 | USD 75.75 | USD 136,350 | SEC 申报 ↗ |
| 2026-03-11 | Poletti Franco | 期权行权／转换 (M) | Ordinary Shares | 2,140 | USD 57.60 | USD 123,264 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | LIVN |
| CIK | 0001639691 |
| 行业 | Healthcare |
| 细分行业 | Medical Devices Yahoo Finance |
| SEC SIC | 3845 Electromedical & Electrotherapeutic Apparatus |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 448 transaction lines from 2020-01-02 to 2026-09-10 2 P purchase lines · 32 S sale lines · 414 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.